公开(公告)号：US11352323B2

公开(公告)日：2022-06-07

申请号：US17145109

申请日：2021-01-08

Applicant: Journey Medical Corporation

Inventor： Anthony Adrian Shaw

IPC: C07D207/12 ,  C07B57/00 ,  A61P43/00

Abstract: Provided herein are processes for making and methods of using salts of glycopyrronium, including solid forms and forms suitable for use as topicals. Disclosed here are processes for making salts of glycopyrronium, also processes for making compositions comprising salts of glycopyrronium, and methods of treating hyperhidrosis with salts of glycopyrronium as well as with compositions comprising salts of glycopyrronium such as, but not limited to, topical compositions. Disclosed herein are methods of treating hyperhidrosis including administering salts of glycopyrronium to subjects in need thereof.

公开(公告)号：US11291652B2

公开(公告)日：2022-04-05

申请号：US16917677

申请日：2020-06-30

Applicant: Journey Medical Corporation

Inventor： John Allan Statler ,  Anthony Adrian Shaw ,  Delphine Caroline Imbert ,  Jennifer Leigh Nelson ,  Patricia Andres ,  Lisa Lynn McQueen ,  Stephan Xander Mattheus Boerrigter ,  Jon Gordon Selbo ,  Mark Christopher Andres

IPC: C07D207/12 ,  A61K31/40 ,  A61K9/00 ,  A61K9/08 ,  A61K47/10 ,  A61K47/12 ,  A61K47/32 ,  A61K47/34

Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

公开(公告)号：US11542232B2

公开(公告)日：2023-01-03

申请号：US16798160

申请日：2020-02-21

Applicant: Journey Medical Corporation

Inventor： Anthony Adrian Shaw ,  Enrico Vigano ,  Renato Molteni

IPC: C07D207/12 ,  C07C309/73 ,  C07C303/22 ,  C07C201/12 ,  C07C309/30 ,  B01D9/00 ,  C07C63/24 ,  C07C67/08 ,  C07C69/608 ,  C07F11/00

Abstract: Provided herein are methods for the production of glycopyrronium tosylate and glycopyrronium tosylate compositions. Also provided herein are compositions useful in the production of glycopyrronium tosylate. Additionally provided herein are glycopyrronium tosylate compositions. Glycopyrronium tosylate is useful for the treatment of, among other conditions, hyperhidrosis.

公开(公告)号：US11291651B2

公开(公告)日：2022-04-05

申请号：US16737747

申请日：2020-01-08

Applicant: Journey Medical Corporation

Inventor： John Allan Statler ,  Anthony Adrian Shaw ,  Delphine Caroline Imbert ,  Jennifer Leigh Nelson ,  Patricia Andres ,  Lisa Lynn McQueen ,  Stephan Xander Mattheus Boerrigter ,  Jon Gordon Selbo ,  Mark Christopher Andres

IPC: A61K31/40 ,  C07D207/12 ,  A61K9/00 ,  A61K9/08 ,  A61K47/10 ,  A61K47/12 ,  A61K47/32 ,  A61K47/34

Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.